Research Paper
Determination of terminal glycan and total monosaccharide profiles of reelin glycoprotein in SH-SY5Y neuroblastoma cell line by lectin blotting and capillary liquid chromatography electrospray ionization-ion trap tandem mass spectrometry system

https://doi.org/10.1016/j.bbapap.2020.140559Get rights and content

Highlights

  • Reelin was detected as distinct fragments (310, 250, and 85 kDa) as well as full-length form (400 kDa) in SH-SY5Y cells

  • The reelin was found to carry the β-GlcNAc, α-Man, β-Gal, and Neu5Ac by lectin blotting.

  • The purified reelin fragment (250 kDa) was found to contain GalNAc, GlcNAc, Gal, Glc, Man and Neu5Ac by CapLC-ESI-MS/MS.

  • This is the first study for the characterization of reelin glycoprotein with CapLC-ESI-MS/MS system.

Abstract

Reelin (400 kDa) is an extracellular matrix glycoprotein that is a key regulator of the many significant biological processes including the brain formation, cell aggregation, and dendrite formation. The glycosylation contributes to the nature of the protein through folding, localization and trafficking, solubility, antigenicity, biological activity, and half-life. Although reelin is to be known as a glycoprotein, the knowledge of its glycosylation is very limited. In this study, we aimed to characterize the terminal glycan profile of reelin by lectin blotting and monosaccharide analysis of glycan chains by capillary liquid chromatography electrospray ionization ion trap tandem mass spectrometry (CapLC-ESI-MS/MS) in SH-SY5Y neuroblastoma cell line. According to our results, reelin was detected in different protein fragments (310, 250, and 85 kDa) in addition to full-length form (400 kDa) in the cell line. The reelin glycoprotein was found to carry the β-N-Acetylglucosamine, α-Mannose, β-Galactose, and α-2,3 and α2,6 linked sialic acids by lectin blotting. Nevertheless, these terminal monosaccharides were found in different intensity according to reelin fragments. Besides, we purified a reelin fragment (250 kDa), and we analyzed it for their monosaccharide by CapLC-ESI-MS/MS. We found that reelin contained five types of monosaccharides, which were consisted of N-Acetylgalactosamine, N-Acetylglucosamine, Galactose, Glucose, Mannose and Sialic acid, from high to low abundance respectively. The present results provide a valuable guide for biochemical, genetic, and glycobiology based further experiments about reelin glycosylation in cancer perspective.

Introduction

Protein glycosylation is the most widespread co- and post-translational modification, which is resulting in the addition of carbohydrates to proteins. During the cellular interaction events, it actually affects proteins by means of folding, localization and trafficking, protein solubility, antigenicity, biological activity, and half-life [1,2]. There are two main types of protein glycosylation, which are termed as N- and O- linked glycosylation. The first one, called N-glycosylation, is identified by attachment of precursor oligosaccharide, GlcNAc2-Man9-Glc3, from the dolichol-linked pyrophosphate donor to the amino side chain of the asparagine (Asn) amino acid within a consensus sequence of Asn-Xaa-Ser/Thr (Xaa is any amino acid except Pro) on proteins. The second one, called O-glycosylation, is identified by attachment of monosaccharide/glycan units to the hydroxyl side chain of serine(Ser) or threonine(Thr) amino acids of proteins [3]. Following the transfer of glycan to the polypeptide, N- and O- linked glycans have been processed to construct the structure of mature glycan by a variety of glycosidase and glycosyltransferase enzymes [4,5]. The process significantly influences biochemical, physicochemical, and structural characteristics of glycoproteins [6].

Reelin (400 kDa) is an extracellular glycoprotein composed of approximately 3461 amino acids and secreted mainly from the Cajal-Retzius cells in the marginal zone of the developing cortex and a subpopulation of GABAergic interneuron in the mature brain [7]. It acts as a key regulator of several biological processes in laminar formation including neuronal migration, cell aggregation, and dendrite formation [8]. From the N- to the C-termini, reelin is composed of a signal peptide, F-Spondin-like domain, unique region called ‘H' subdivided into three subdomains termed X, Y, Z and eight tandem reelin repeats (RR1 to 8) followed by basic C-terminal domain respectively. Each of these repeats includes epidermal growth factor (EGF) like motif at its center and links up two sub-repeats [9,10].

During the reelin signaling pathway, it activates the tyrosine phosphorylation-dependent signal transduction [11,12]. When the reelin binds to its receptors, very low density lipoprotein receptor (VLDLR) and apolipoprotein E receptor 2 (ApoER2) [[13], [14], [15]], it induces phosphorylation of the adapter protein disabled-1 (Dab1) through the Src family tyrosine kinases (SFKs) Fyn and Src [16,17]. Phosphorylated Dab1 in turn recruits several signaling molecules, including the Crk family adaptor proteins, Crk and CrkL, [18]. Alternatively, it is identified that reelin signaling activates the integrin α5β1 [19] and N-Cadherin [20].

Although reelin is to be known as a glycoprotein, there is limited knowledge about its glycosylation. Reelin actually possesses a mass of N-linked and a little O-linked glycan [21]. Recent data has shown that reelin glycosylation could be important in non-neurodegenerative diseases and some types of cancers [22]. In some neurological diseases including Alzheimer's disease, reelin glycosylation is differentiated, when it is compared to healthy (control) groups [23]. Our preliminary bioinformatics data have shown that reelin carries a variety of possible N- and O-glycosylation positions (Unpublished). However, there is no detailed information about glycosylation capacity, which is obtained analytical techniques such as liquid chromatography-mass spectrometry. In this study, we aimed to characterize the terminal glycan profile of reelin by lectin blotting and monosaccharide analysis of glycan chains by CapLC-ESI-MS/MS.

Section snippets

Material

The SH-SY5Y neuroblastoma cell line (ATCC® CRL-2266™) was used to obtain total and cytoplasmic protein extracts to work with reelin glycoprotein, because it is neuronal and cancer origin.

Cell culture

The SH-SY5Y neuroblastoma cells were grown in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS, SEROX), 2 mM l-glutamine (Sigma) and 50 μg/ml Gentamicin (Sigma). Cells were maintained at 37 °C in a saturated humidity atmosphere containing 95% air and 5% CO2. Cells were

Determination of reelin glycoprotein in SH-SY5Y neuroblastoma cell line

Prior to identifying the terminal glycan profile and total monosaccharide analysis of reelin, we determined the reelin in SH-SY5Y neuroblastoma cell line with two different extraction methods, which provide total and cytoplasmic proteins. In total protein extraction, we determined two reelin fragments, ~310 and ~ 250 kDa, as characteristic reelin bands. In addition, a reelin fragment of ~85 kDa was determined when using the same antibody and blotting conditions (Fig. 1a). In cytoplasmic protein

Discussion

The alteration and differentiation of glycan structures and monosaccharide contents of glycoproteins are able to regulate protein function by changing their microenvironment [31]. Protein glycosylation also affects some cellular processes including the dysfunction of cell cycling, the rigidity of extracellular matrix and basal membrane, promoting the cell growth, proliferation, angiogenesis, and prevent of recognition from the immune system [32]. These changes can result in the formation of

Declaration of Competing Interest

The authors have no conflict of interest to declare.

Acknowledgements

This work was supported by the Ege University Scientific Research Projects Coordination Unit [grant numbers 18-FEN-019].

References (49)

  • S.J. Franco et al.

    Reelin regulates cadherin function via Dab1/Rap1 to control neuronal migration and lamination in the neocortex

    Neuron

    (2011)
  • S. Honda et al.

    High-performance liquid chromatography of reducing carbohydrates as strongly ultraviolet-absorbing and electrochemically sensitive 1-phenyl-3-methyl5-pyrazolone derivatives

    Anal. Biochem.

    (1989)
  • S. İzzetoğlu et al.

    Determination of sialic acids in immune system cells (coelomocytes) of sea urchin, Paracentrotus lividus, using capillary LC-ESI-MS/MS

    Fish & shellfish immunology

    (2014)
  • A.P. Corfield et al.

    Glycan variation and evolution in the eukaryotes

    Trends Biochem. Sci.

    (2015)
  • S. Kohno et al.

    Mechanism and significance of specific proteolytic cleavage of Reelin

    Biochemical and biophysical research communications

    (2009)
  • D. Benhayon et al.

    Binding of purified Reelin to ApoER2 and VLDLR mediates tyrosine phosphorylation of Disabled-1

    Mol. Brain Res.

    (2003)
  • N. Ignatova et al.

    Characterization of the various forms of the Reelin protein in the cerebrospinal fluid of normal subjects and in neurological diseases

    Neurobiol. Dis.

    (2004)
  • R. Schauer

    Sialic acids: fascinating sugars in higher animals and man

    Zoology

    (2004)
  • C.T. Yuen et al.

    Brain contains HNK-1 immunoreactive O-glycans of the sulfoglucuronyl lactosamine series that terminate in 2-linked or 2, 6-linked hexose (mannose)

    J. Biol. Chem.

    (1997)
  • A. Corfield

    Eukaryotic protein glycosylation: a primer for histochemists and cell biologists

    Histochem. Cell Biol.

    (2017)
  • M.E. Taylor et al.

    Introduction to Glycobiology

    (2011)
  • L.L. Lairson et al.

    Glycosyltransferases: structures, functions, and mechanisms

    Annu. Rev. Biochem.

    (2008)
  • D.S. Rice et al.

    Role of the reelin signaling pathway in central nervous system development

    Annu. Rev. Neurosci.

    (2001)
  • G. D’Arcangelo et al.

    A protein related to extracellular matrix proteins deleted in the mouse mutant reeler

    Nature

    (1995)
  • Cited by (0)

    1

    Present address: Ramiz Demir, Koç University, School of Medicine, Koç University Research Center for Translational Medicine (KUTTAM), 34010, Istanbul-TURKEY.

    View full text